These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15377875)

  • 1. MPTP as a mitochondrial neurotoxic model of Parkinson's disease.
    Przedborski S; Tieu K; Perier C; Vila M
    J Bioenerg Biomembr; 2004 Aug; 36(4):375-9. PubMed ID: 15377875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.
    Ren Z; Yang N; Ji C; Zheng J; Wang T; Liu Y; Zuo P
    Neuropharmacology; 2015 Jun; 93():209-18. PubMed ID: 25680233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
    Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
    Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
    Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Singh A; Verma P; Balaji G; Samantaray S; Mohanakumar KP
    Neurochem Int; 2016 Oct; 99():221-232. PubMed ID: 27395789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical findings in the MPTP model of Parkinson's disease.
    Schmidt N; Ferger B
    J Neural Transm (Vienna); 2001; 108(11):1263-82. PubMed ID: 11768626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
    Lee Y; Park HR; Chun HJ; Lee J
    J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
    Domenger D; Dea D; Theroux L; Moquin L; Gratton A; Poirier J
    Exp Neurol; 2012 Jan; 233(1):513-22. PubMed ID: 22155743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Mitochondrial Subproteome of Rpn10-Binding Proteins and Its Changes Induced by the Neurotoxin MPTP and the Neuroprotector Isatin.
    Medvedev AE; Buneeva OA; Kopylov AT; Tikhonova OV; Medvedeva MV; Nerobkova LN; Kapitsa IG; Zgoda VG
    Biochemistry (Mosc); 2017 Mar; 82(3):330-339. PubMed ID: 28320274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.
    Lee KM; Lee Y; Chun HJ; Kim AH; Kim JY; Lee JY; Ishigami A; Lee J
    J Neurosci Res; 2016 Oct; 94(10):865-78. PubMed ID: 27265894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
    Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
    Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain upregulation in spinal cords of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease.
    Ray SK; Wilford GG; Ali SF; Banik NL
    Ann N Y Acad Sci; 2000 Sep; 914():275-83. PubMed ID: 11085327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
    J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.
    Delgado M; Ganea D
    FASEB J; 2003 May; 17(8):944-6. PubMed ID: 12626429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease?
    Dovero S; Gross C; Bezard E
    Synapse; 2016 Feb; 70(2):49-51. PubMed ID: 26583879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
    Watanabe Y; Himeda T; Araki T
    Med Sci Monit; 2005 Jan; 11(1):RA17-23. PubMed ID: 15614202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.